Markets:

Overview

News

Currencies

International

Treasuries

Bayer Ag ADR (OP:BAYRY)

11.23 +0.35 (+3.26%)

Streaming Delayed Price Updated: 11:54 AM EDT, May 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag ADR

< Previous 1 2 3 4 5 6 7 8 9 Next >

Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis

May 07, 2026

From Bayer

Via Business Wire

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline

May 06, 2026

From Bayer

Via Business Wire

Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

April 29, 2026

From Bayer

Via Business Wire

New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing

April 29, 2026

From Bayer

Via Business Wire

Record-Breaking US Soybean Planting Pace Clouds Futures Market

April 15, 2026

The United States Department of Agriculture (USDA) sent ripples through the commodities markets this week with the release of its latest Crop Progress report, revealing that U.S. soybean planting has...

Via MarketMinute

Midwest Planting Delays Loom as NOAA Predicts Heavy April Rains

April 13, 2026

As the mid-April sun typically signals the start of the heavy planting season across the American heartland, the 2026 season is proving to be a frustrating exercise in patience. Farmers across the Corn...

Via MarketMinute

USDA Stuns Markets as April WASDE Raises Farm Gate Prices Amid Domestic Supply Crunch

April 10, 2026

The United States Department of Agriculture (USDA) sent shockwaves through the agricultural sector this morning with the release of the April 2026 World Agricultural Supply and Demand Estimates (WASDE)...

Via MarketMinute

Topics Economy Energy

Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

March 31, 2026

From Bayer

Via Business Wire

Multiplatinum Rapper, Actor Ludacris Partners with One A Day® to Help People Realize that Health Does Not Need to Be Ludacris

March 26, 2026

From Bayer

Via Business Wire

The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush

March 18, 2026

As of March 18, 2026, the corporate landscape has undergone a radical transformation. The era of the sprawling global conglomerate, once the gold standard of industrial stability, is rapidly giving way...

Via MarketMinute

Topics Artificial Intelligence Economy

KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease

March 16, 2026

From Bayer

Via Business Wire

New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments

March 04, 2026

From Bayer

Via Business Wire

The Section 122 Pivot: How a 10% Global Tariff is Reshaping the 2026 Market Landscape

March 03, 2026

The global financial markets have entered a period of profound "legalized volatility" following the White House’s emergency invocation of Section 122 of the Trade Act of 1974. This move, triggered by a...

Via MarketMinute

Topics Economy Electric Vehicles Government

The Strategic Crossroads of FMC Corporation: A 2026 Research Deep Dive

March 03, 2026

Date: March 3, 2026 Introduction FMC Corporation (NYSE: FMC) currently finds itself at one of the most pivotal junctures in its 140-year history. Once a darling of the agricultural sector known for its...

Via Finterra

Topics Economy Intellectual Property World Trade

The Great Grain Pivot: USDA Forecasts Record Soy Surge as Corn Retreats in 2026

March 02, 2026

The American agricultural landscape is undergoing a massive structural shift as the 2026 planting season approaches. According to the U.S. Department of Agriculture's (USDA) 102nd Agricultural Outlook...

Via MarketMinute

Topics Energy

Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

February 27, 2026

From Bayer

Via Business Wire

Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases

February 26, 2026

From Bayer

Via Business Wire

European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO

February 23, 2026

In a landmark decision for the cardiovascular treatment landscape, the European Commission (EC) officially granted marketing authorization to Cytokinetics, Inc. (Nasdaq: CYTK) on February 17, 2026, for...

Via MarketMinute

Topics Intellectual Property

Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA

February 23, 2026

From Bayer

Via Business Wire

Bayer's $7.25 Billion Roundup Settlement: A 21-Year Plan for Certainty

February 18, 2026

Bayer AG (OTC: BAYRY) has announced a sweeping $7.25 billion proposed class action settlement aimed at resolving the vast majority of its remaining U.S. litigation involving the weedkiller Roundup....

Via MarketMinute

Topics Lawsuit

Uncle Sam’s $44.36 Per Acre Gamble: How Government Intervention is Distorting the 2026 Planting Season

February 18, 2026

As the 2026 planting season approaches, American farmers are facing a paradox of record-low commodity prices and unprecedented government support. The centerpiece of this intervention is the newly...

Via MarketMinute

Topics Economy

German Pharma Giant Bayer Proposes $7.25 Billion Settlement Over Monsanto's Roundup Cancer Claims In US ↗

February 18, 2026

Bayer AG (OTC: BAYRY) on Tuesday proposed a $7.25 billion settlement to resolve thousands of U.S. lawsuits claiming that its weedkiller Roundup causes cancer. The product was originally made by...

Via Benzinga

Topics Lawsuit

Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data

February 16, 2026

The multi-billion dollar wet Age-Related Macular Degeneration (wet AMD) market is standing on the precipice of a transformative shift. Today, February 16, 2026, Ocular Therapeutix (NASDAQ: OCUL) is in...

Via MarketMinute

Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month

February 12, 2026

From Bayer

Via Business Wire

Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo

February 05, 2026

From Bayer

Via Business Wire

Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign

January 29, 2026

From Bayer

Via Business Wire

Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention

January 27, 2026

From Bayer

Via Business Wire

Wall Street’s ‘Fear Gauge’ Reclaims the 20 Mark: Why the Greenland Tariff Threat and Earnings Redlining Triggered a Market Reset

January 20, 2026

The CBOE Volatility Index (VIX), often hailed as the stock market’s “fear gauge,” surged past the critical 20.00 threshold on January 20, 2026, marking a significant shift in investor sentiment as the...

Via MarketMinute

Topics Economy Government Stocks

Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases

January 20, 2026

From Bayer

Via Business Wire

The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026

January 16, 2026

As of January 16, 2026, Moderna, Inc. (NASDAQ: MRNA) stands at a critical crossroads. Once the poster child for the biotechnology industry’s rapid response to a global pandemic, the Cambridge-based...

Via Finterra

Topics Initial Public Offering Intellectual Property Lawsuit

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.